Detalhe da pesquisa
1.
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial.
Gynecol Oncol
; 184: 168-177, 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38325276
2.
Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study.
Gynecol Oncol
; 164(2): 398-405, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34857397
3.
Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC).
Gynecol Oncol
; 161(2): 382-388, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33712274
4.
Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer.
Gynecol Oncol
; 163(2): 246-253, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34620496
5.
The "Far Left" of the Morphologic Spectrum of Ovarian High-grade Serous Carcinoma: Case Report of a Purely Noninvasive High-grade Serous Carcinoma Mimicking an Ovarian Serous Borderline Tumor.
Int J Gynecol Pathol
; 40(2): 175-179, 2021 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32168063
6.
Bevacizumab-associated thrombotic microangiopathy treated with eculizumab: A case series and systematic review of the literature.
Clin Nephrol
; 96(1): 51-59, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33896447
7.
Performance of lymphadenectomy for apparent early stage malignant ovarian germ cell tumors in the era of platinum-based chemotherapy.
Gynecol Oncol
; 157(3): 613-618, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32359845
8.
Radical hysterectomy is not associated with a survival benefit for patients with stage II endometrial carcinoma.
Gynecol Oncol
; 157(2): 335-339, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32089334
9.
Advanced stage primary mucinous ovarian carcinoma. Where do we stand ?
Arch Gynecol Obstet
; 301(4): 1047-1054, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32185553
10.
Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinoma.
Gynecol Oncol
; 154(2): 302-307, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31155308
11.
Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.
Gynecol Oncol
; 154(2): 420-425, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31229298
12.
A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer.
Gynecol Oncol
; 154(2): 294-301, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31174889
13.
Outcomes of secondary cytoreductive surgery for patients with platinum-sensitive recurrent ovarian cancer.
Am J Obstet Gynecol
; 221(6): 625.e1-625.e14, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31207237
14.
Low rate of intraperitoneal port placement in ovarian cancer patients, a population-based assessment.
Int J Gynecol Cancer
; 29(7): 1177-1181, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31302627
15.
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
Lancet
; 390(10103): 1654-1663, 2017 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28756902
16.
Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm.
Oncologist
; 23(12): 1533-1545, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30139839
17.
Are patients willing to travel for better ovarian cancer care?
Gynecol Oncol
; 148(1): 42-48, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29079037
18.
Phase II evaluation of dalantercept in the treatment of persistent or recurrent epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 150(3): 466-470, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30041929
19.
Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 149(3): 525-530, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29550184
20.
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
Gynecol Oncol
; 147(2): 243-249, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28807367